Fibrinogen Biosynthesis

Abstract: Plasma fibrinogen is synthesized primarily in hepatocytes and assembly of the three component chains (Aα, Bβ, and γ) into its final form as a six‐chain dimer (Aα, Bβ, γ)2 occurs rapidly in the lumen of the endoplasmic reticulum (ER). Assembly takes place in a stepwise manner with single chains interacting with each other to form Aα‐γ and Bβ‐γ complexes. The two‐chain complexes then acquire another chain to form half‐molecules (Aα, Bβ, γ)1, which in a final step are linked to form the six‐chain (Aα, Bβ, γ)2 complex. As with other secreted glycoproteins, N‐linked glycosylation of Bβ and γ chains commences in the ER and is completed in Golgi organelles. Sulfation and phosphorylation occur at post‐ER stages of the secretory process. Since some ER chaperones coisolate with nascent fibrinogen chains they have been implicated in assisting chain assembly. Studies with recombinant systems, using deletion and substitution mutants, indicate that initial chain assembly depends on hydrophobic interactions present in the C‐terminal half of the coil‐coil domains and that inter‐ and intra‐disulfide bonds that stabilize fibrinogen are needed to complete chain assembly. Not all the chains that are synthesized are assembled into fibrinogen and the unassembled chains are not secreted. HepG2 cells contain surplus Aα and γ chains that accumulate as free γ chains and as an Aα‐γ complex. Aα‐γ is degraded by lysosomes whereas the γ chain is degraded by the proteasome‐ubiquitin system. Studies with expression of single chains by COS cells confirm that γ and Bβ are hydrolyzed by proteasomes and indicate that Aα is degraded partially both by lysosomes and proteasomes. The role of surplus chains in regulating fibrinogen assembly is not understood but overexpression of any one chain, elicited by transfection of HepG2 cells, results in the upregulation of the other two genes, increased fibrinogen synthesis and secretion, and maintenance of surplus intracellular Aα and γ chains. HepG2 cells, programmed in this manner to increase basal fibrinogen expression, have higher HMG‐CoA reductase mRNA levels, enhanced cholesterol and cholesterol ester synthesis, and increased secretion of apolipoprotein B (apoB). Overexpression of basal levels of fibrinogen does not affect synthesis of other acute phase proteins. Enhanced secretion of apoB is due to diminished degradation of nascent apoB by proteasomes and not to increased expression. Increased secretion of apoB is associated with increased basal expression of fibrinogen and is not affected when fibrinogen expression is stimulated by interleukin‐6. In HepG2 cells, a feedback mechanism exists and extracellular sterols specifically downregulate expression of the three fibrinogen genes. These studies link, at the cellular level, basal fibrinogen expression with lipid metabolism.

[1]  C. Redman,et al.  Enhanced secretion of ApoB by transfected HepG2 cells overexpressing fibrinogen. , 2000, Biochemical and biophysical research communications.

[2]  A Helenius,et al.  Setting the standards: quality control in the secretory pathway. , 1999, Science.

[3]  A. Hamsten,et al.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  C. Redman,et al.  The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway. , 1999, Biochemical and biophysical research communications.

[5]  P. Barrett,et al.  Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. , 1999, Journal of lipid research.

[6]  Roger A. Davis,et al.  Translocation-arrested Apolipoprotein B Evades Proteasome Degradation via a Sterol-sensitive Block in Ubiquitin Conjugation* , 1999, The Journal of Biological Chemistry.

[7]  Y. Fu,et al.  Formation of the human fibrinogen subclass fib420: disulfide bonds and glycosylation in its unique (alphaE chain) domains. , 1998, Blood.

[8]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[9]  J. Bonifacino,et al.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways. , 1998, Annual review of cell and developmental biology.

[10]  J. Burnett,et al.  Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[11]  G. Watts,et al.  Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. , 1997, The American journal of physiology.

[12]  S. Ōmura,et al.  The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70* , 1997, The Journal of Biological Chemistry.

[13]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[14]  D. Levy,et al.  Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. , 1997, Circulation.

[15]  E. Davie,et al.  The role of betagamma and alphagamma complexes in the assembly of human fibrinogen. , 1996, The Journal of biological chemistry.

[16]  L. Chan,et al.  Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. , 1996, Biochemistry.

[17]  A. Sun,et al.  In Vitro Assembly of the Component Chains of Fibrinogen Requires Endoplasmic Reticulum Factors* , 1996, The Journal of Biological Chemistry.

[18]  B. Blombäck Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis. , 1996, Thrombosis research.

[19]  R. McLeod,et al.  The Microsomal Triglyceride Transfer Protein Facilitates Assembly and Secretion of Apolipoprotein B-containing Lipoproteins and Decreases Cotranslational Degradation of Apolipoprotein B in Transfected COS-7 Cells* , 1996, The Journal of Biological Chemistry.

[20]  C. Redman,et al.  Assembly and Secretion of Fibrinogen , 1996, The Journal of Biological Chemistry.

[21]  E. Davie,et al.  The assembly of human fibrinogen. The role of the amino-terminal and coiled-coil regions of the three chains in the formation of the alphagamma and betagamma heterodimers and alphabetagamma half-molecules. , 1996, The Journal of biological chemistry.

[22]  G. Ghiselli,et al.  Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. , 1996, Journal of lipid research.

[23]  P. Barrett,et al.  Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  Y. Fu,et al.  Fib420: a normal human variant of fibrinogen with two extended alpha chains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Reed,et al.  Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study , 1994, Clinical genetics.

[26]  C. Redman,et al.  Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. , 1994, The Journal of biological chemistry.

[27]  C. Redman,et al.  Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. , 1994, The Journal of biological chemistry.

[28]  Donald A. Smith Fibrinogen as a cardiovascular risk factor: a meta-analysis , 1993, ACP Journal Club.

[29]  B. Kudryk,et al.  Symmetrical disulfide bonds are not necessary for assembly and secretion of human fibrinogen. , 1993, The Journal of biological chemistry.

[30]  E. Davie,et al.  Processing of the carboxyl 15-amino acid extension in the alpha-chain of fibrinogen. , 1993, The Journal of biological chemistry.

[31]  E. Mulvihill,et al.  Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly. , 1993, The Journal of biological chemistry.

[32]  H. Ginsberg,et al.  Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. , 1993, Journal of lipid research.

[33]  E. Davie,et al.  The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen. , 1993, Biochemical and biophysical research communications.

[34]  Y. Fu,et al.  Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits. , 1992, Biochemistry.

[35]  S. Yu,et al.  Assembly and secretion of fibrinogen. Degradation of individual chains. , 1992, The Journal of biological chemistry.

[36]  C. Redman,et al.  Identification of B beta chain domains involved in human fibrinogen assembly. , 1992, The Journal of biological chemistry.

[37]  E. Davie,et al.  Recombinant human fibrinogen and sulfation of the gamma' chain. , 1991, Biochemistry.

[38]  K. Danishefsky,et al.  Studies on the assembly and secretion of fibrinogen. , 1991, The Journal of biological chemistry.

[39]  B. Kudryk,et al.  Assembly and secretion of recombinant human fibrinogen. , 1991, The Journal of biological chemistry.

[40]  J. Borén,et al.  The molecular mechanism for the assembly and secretion of ApoB-100-containing lipoproteins. , 1991, Progress in lipid research.

[41]  K. Cianflone,et al.  Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. , 1990, Journal of lipid research.

[42]  C. Redman,et al.  Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. , 1990, The Journal of biological chemistry.

[43]  C. Redman,et al.  Intracellular fate of fibrinogen Bβ chain expressed in COS cells , 1990 .

[44]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[45]  J. Harris,et al.  Nucleotide sequences of the three genes coding for human fibrinogen. , 1990, Advances in experimental medicine and biology.

[46]  D. Banerjee,et al.  Intracellular fate of fibrinogen B beta chain expressed in COS cells. , 1990, Biochimica et biophysica acta.

[47]  P. Kierulf,et al.  DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration , 1989, Clinical genetics.

[48]  H. Baumann,et al.  IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. , 1989, Journal of immunology.

[49]  Y. Ikehara,et al.  Biosynthesis, assembly and secretion of fibrinogen in cultured rat hepatocytes. , 1988, The Biochemical journal.

[50]  M. Blombäck,et al.  GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATION , 1987, The Lancet.

[51]  P. W. Plant,et al.  Noncoordinate synthesis of the fibrinogen subunits in hepatocytes cultured under hormone-deficient conditions. , 1986, The Journal of biological chemistry.

[52]  S. Yu,et al.  Fibrinogen precursors. Order of assembly of fibrinogen chains. , 1984, The Journal of biological chemistry.

[53]  S. Yu,et al.  Intracellular assembly of human fibrinogen. , 1983, The Journal of biological chemistry.

[54]  G. Crabtree,et al.  Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Southan,et al.  COVALENT STRUCTURE OF FIBRINOGEN , 1983, Annals of the New York Academy of Sciences.

[56]  E. Davie,et al.  CLONING OF FIBRINOGEN GENES AND THEIR cDNA * , 1983, Annals of the New York Academy of Sciences.

[57]  R. Kalb,et al.  HORMONAL REGULATION OF FIBRINOGEN SYNTHESIS IN CULTURED HEPATOCYTES * , 1983, Annals of the New York Academy of Sciences.

[58]  G. Crabtree,et al.  The rat fibrinogen genes. Linkage of the A alpha and gamma chain genes. , 1983, The Journal of biological chemistry.

[59]  J. Finlayson,et al.  Rabbit fibrinogen: time course of constituent chain production in vivo. , 1982, Archives of biochemistry and biophysics.

[60]  G. Crabtree,et al.  Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination. , 1982, The Journal of biological chemistry.

[61]  B. Kudryk,et al.  Biosynthesis of dog fibrinogen. Characterization of nascent fibrinogen in the rough endoplasmic reticulum. , 1982, European journal of biochemistry.

[62]  G. Crabtree,et al.  Molecular cloning of cDNA for the alpha, beta, and gamma chains of rat fibrinogen. A family of coordinately regulated genes. , 1981, The Journal of biological chemistry.

[63]  J. Nickerson,et al.  Modification of fibrinogen chains during synthesis: glycosylation of B beta and gamma chains. , 1981, Biochemistry.

[64]  H. Clink,et al.  Letter: Quality and quantity of survival in acute myeloid leukaemia. , 1975, Lancet.

[65]  S. Iwanaga,et al.  Primary structure of human fibrinogen and fibrin. II. Structural studies on NH2-terminal part of gamma chain. , 1973, The Journal of biological chemistry.